Madagascar places an order for vaccines to fight monkeypox

Mis à jour le 21 May 2026

Madagascar Launches Strategic Mobilization for Monkeypox Vaccine Imports

Faced with an emerging monkeypox epidemic, Madagascar is at a crucial turning point in its public health management. The decision to import vaccines, announced earlier this year by the Minister of Health, Magnana Monira, demonstrates a firm commitment to combating the spread of this infectious disease. This initiative comes at a time when several Indian Ocean countries, as well as the international community, have expressed concerns about an increase in cases in 2026. Priority is now being given to a targeted prevention strategy to limit infections and strengthen the population’s immunization capacity.

This process requires the full mobilization of health authorities, in close collaboration with the World Health Organization, to ensure reception in accordance with international standards and efficient distribution. The order initially targets healthcare professionals, vulnerable individuals, and the most at-risk regions, aiming to implement temporary immunization while awaiting the optimization of global vaccination campaigns. From a logistical standpoint, Madagascar also faces significant challenges, particularly in terms of storage, transportation, and public awareness. This situation has sparked a lively debate surrounding prevention, epidemiology, and the role of international cooperation in combating emerging infectious diseases.

The health situation in Madagascar: assessment and ongoing measures to curb the spread of the virus.

Since the start of the mox outbreak in Madagascar, about ten suspected cases have been confirmed. The government quickly implemented enhanced surveillance while emphasizing that no deaths have been recorded to date. The majority of patients, diagnosed in the capital and some southeastern regions, have received symptomatic treatment and rigorous medical monitoring. This proactive approach, combined with constant communication with the population, has made it possible to partially contain the disease, despite the active circulation of the virus on the island.

Health authorities have also officially established four specialized centers dedicated to the management of mox cases. These facilities, strategically located in the main transmission areas, are tasked with providing testing, ensuring isolation, and administering vaccinations. Their role complements a prevention strategy that includes strengthening hygiene measures and raising awareness about social distancing. This fast-track organization is part of a medium-term crisis management approach, anticipating any escalation of the epidemic. The establishment of these structures demonstrates Madagascar’s commitment to leaving no stone unturned in the fight against this emerging infectious disease.

The challenges related to vaccine importation: a crucial step for Malagasy public health.

The order of monkeypox vaccines marks a turning point in the response to the epidemic. According to Magnana Monira, the strategy prioritizes high-risk populations, including healthcare professionals, vulnerable individuals, and those living in enclosed or densely populated areas. The selection process is based on a rigorous analysis of the current epidemiological profile, which reveals limited spread but persistent circulation of the virus. The major challenge is to anticipate any new wave and ensure effective immunization, while avoiding panic and social stigma.

For several years, Madagascar has faced a variety of health challenges, including managing epidemics. While ordering vaccines is a proactive step, it requires collective support and appropriate logistics. Raising awareness about vaccination and prevention is essential to ensure public acceptance. The government has emphasized the need to strengthen its health capacity to guarantee lasting immunization, particularly by using vaccines approved by the WHO or those with exceptional authorization. The success of this operation will depend on coordination between authorities, international partners, and local stakeholders involved in the fight against monkeypox.

Impact of the vaccine in the overall disease prevention strategy

The monkeypox vaccine appears to be an essential tool to complement prevention measures. Its role is not limited to simple immunization; it also serves as a lever to reduce virus transmission. The scientific community recognizes that targeted vaccination can help curb the spread, particularly in a context where the disease exhibits sporadic but persistent circulation.

Several types of vaccines are recommended, including those based on attenuated viruses or viral vectors, which offer lasting protection against measles. Their effectiveness depends on optimal storage, rapid distribution, and an information campaign to reassure the population. The vaccination strategy must therefore be accompanied by effective communication to dispel doubts and encourage participation. The synergy between vaccination, awareness campaigns, and hygiene measures remains the most robust approach to strengthening the resilience of the Malagasy health system to the disease.

Importing, storing, and administering vaccines in an island environment like Madagascar presents a major logistical challenge. Durability, storage temperature, and traceability are all technical obstacles to overcome. The government has decided to mobilize its local capacities by equipping and training medical and paramedical personnel, while also strengthening cold storage infrastructure.

The vaccination campaign must also incorporate a clear and targeted communication strategy, particularly through multilingual materials and social media campaigns. Coordination with local stakeholders, NGOs, and international partners will be essential to ensure equitable and efficient distribution. Given Madagascar’s specific geographical characteristics, especially its remote rural areas, meticulous planning is crucial to avoid logistical challenges and guarantee optimal vaccination coverage.

2. The Role of International Cooperation in the Eradication of Mpox in Madagascar
3. https://www.youtube.com/watch?v=06258cpg21k
4. The measles epidemic highlights the importance of global solidarity in the face of the threat of infectious diseases. By ordering vaccines, Madagascar demonstrates its commitment to cooperation, particularly with the WHO, UNICEF, and other actors involved in the fight against the disease. The international community can provide technical, scientific, and logistical assistance to strengthen local capacities and ensure a rapid and coherent response.
5. Previous experiences show that implementing such campaigns requires strong political impetus and collective commitment. Prevention must extend beyond borders, integrating cross-border surveillance, ongoing training, and the dissemination of reliable information. Madagascar must therefore operate within a regional and global framework to prevent the potential spread of the epidemic in the Indian Ocean or beyond.

Limiting mox transmission

Specialized centers

Creation and equipping

Ensuring effective medical care

Awareness campaigns

Dissemination of information

Strengthening vaccination and hygiene adherence

What are the risks of not vaccinating against monkeypox in Madagascar?

Failure to vaccinate can lead to a rapid spread of the virus, an overload of the healthcare system, and an increase in severe cases, endangering the vulnerable population.

How does Madagascar plan to overcome the logistical challenges related to vaccination?

The country is focusing on strengthening storage infrastructure, targeted training for medical personnel, and effective coordination with its international partners to ensure rapid and equitable distribution. Will mox vaccination be accessible to everyone?